eHealth Literacy in German Skin Cancer Patients

Int J Environ Res Public Health. 2022 Jul 8;19(14):8365. doi: 10.3390/ijerph19148365.

Abstract

The global incidence of skin cancer has steadily increased in recent years, and malignant melanoma still has one of the fastest-growing incidence rates among all malignant tumors in the western world. Thus, newly diagnosed patients have an increased need for health information concerning their disease. Using a standardized questionnaire, our study aims to investigate our patients' primary sources of health-related information as well as their self-proclaimed eHealth literacy. We received 714 questionnaires. Regardless of age, the primary source of information was the treating dermato-oncologist, followed by the treating general practitioner and the Internet. However, with increasing age, the usage of the Internet decreased. Hence, younger participants were better equipped to find health-related information while using the Internet. Additionally, comprehending health-related information and gaining medical knowledge was significantly increased in better-educated participants. Overall, our study shows that with increased use of eHealth services, accessing web-based information increased, correlating with a better eHealth literacy of our patients. eHealth technologies are increasingly becoming more prevalent as a primary source of information in our modern health care system. Thus, it is crucial to educate cancer patients in eHealth literacy to make autonomous, informed decisions and gain more confidence in dealing with their disease.

Keywords: eHealth; eHealth literacy; health-related information; skin cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Health Literacy*
  • Humans
  • Internet
  • Melanoma* / epidemiology
  • Skin Neoplasms* / epidemiology
  • Surveys and Questionnaires
  • Telemedicine*

Grants and funding

H.S. and M.H. are supported by intramural research funding of the UMC Mainz. M.H. is supported by the Clinician Scientist Fellowship “TransMed Jumpstart Program: 2019_A72” supported by the Else Kröner Fresenius Foundation. S.L. is funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)—CRC1160/2—B03(N), Medical Center—University of Freiburg, and Faculty of Medicine, University of Freiburg.